Clinical Trials
2 trialsNCT05841472 2023-08-30
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
CrystalGenomics, Inc.
Phase 2 Recruiting
NCT05962021 2023-08-01
Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation
Peking University People's Hospital
Phase 2 Not yet recruiting